The WACC of Kinnate Biopharma Inc (KNTE) is 9.4%.
| Range | Selected | |
| Cost of equity | 13.00% - 17.00% | 15.00% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 8.4% - 10.3% | 9.4% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 2 | 2.17 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 13.00% | 17.00% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 8.4% | 10.3% |
| Selected WACC | 9.4% | |